Vizgen, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Jan 12, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Oct 7, 2025 · D | Jan 12, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $9,500,000 | $50,000,000 | $40,500,000 |
| Reported amount sold | $3,500,000 | $47,788,714 | $44,288,714 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001790415-25-000005 · Later SEC source: 0001790415-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $50,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $47,788,714
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001790415-26-000002D · Jan 12, 2026 · BiotechnologyOffering: $50,000,000Sold: $47,788,714
Compared with 0001790415-25-000005:
- Reported offering amount: $9,500,000 → $50,000,000
- Reported amount sold: $3,500,000 → $47,788,714
-
0001790415-25-000005D · Oct 7, 2025 · BiotechnologyOffering: $9,500,000Sold: $3,500,000